FFO
NVCR icon

Fortitude Family Office’s NovoCure NVCR Stock Holding History

Fortitude Family Office’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.75K Hold
110
– – ﹤0.01% 2068
2026
Q2 		$1.67K Buy
+110
New +$1.66K ﹤0.01% 1552
2025
Q3 		– Sell
-30
Closed -$534 – 2094
2025
Q2 		$534 Buy
+30
New +$523 ﹤0.01% 1775

Other funds holding NVCR

Burney Company
Burney Company Reston, Virginia $3.66B AUM 27.59% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
AWA
Aaron Wealth Advisors Chicago, Illinois $2.04B AUM 32.69% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
NAM
NorthCrest Asset Manangement Plymouth, Minnesota $4.24B AUM 32.82% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
EWP
Elevation Wealth Partners Santa Rosa, California $356M AUM 17.04% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return

Fortitude Family Office's NVCR Position: Q3 2026 in Review

Fortitude Family Office held its NovoCure (NVCR) position steady in Q3 2026 at 110 shares worth $1.75K. The position accounts for ﹤0.01% of the portfolio, ranked #2068.

Fortitude Family Office first reported a position in NVCR in Q2 2025 and has held it in 3 quarters since. 19 funds tracked by Wall St. Rank hold NVCR as of Q3 2026.

  • Fortitude Family Office held 110 shares of NovoCure worth $1.75K as of Q3 2026.
  • Fortitude Family Office left its NovoCure share count unchanged in Q3 2026.
  • NovoCure made up ﹤0.01% of Fortitude Family Office's portfolio in Q3 2026, its #2068 holding.
  • Fortitude Family Office first reported a position in NovoCure in Q2 2025 and has held it in 3 quarters since.
  • 19 funds tracked by Wall St. Rank held NovoCure as of Q3 2026.

Based on Fortitude Family Office's 13F filing for Q3 2026, filed 14 Oct 2026.